FDA Drug Application (018817) for CALAN by GD SEARLE LLC

Back to FDA Applications sponsored by GD SEARLE LLC

Application Number018817
Product Number001
FormTABLET;ORAL
Dosage80MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameCALAN
Active IngredientVERAPAMIL HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient VERAPAMIL HYDROCHLORIDE10


Back to FDA Applications sponsored by GD SEARLE LLC